Tablet:The Ruling Dosage Form Since Years/References
From Pharmpedia
< Tablet:The Ruling Dosage Form Since Years
Go to Contents of Tablet:The Ruling Dosage Form Since Years>>>>>
1. Lachman L., Liberman H. and Kanig J.; The Theory and Practice of Industrial Pharmacy; Third Edition: 293-345, 346-373.
2. Aulton M.; Pharmaceutics: The Science of Dosage Form Design; International Student Edition: 304-321, 347-668.
3. Ansel H., Allen L. and Jr. Popovich N.; Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems; Eighth Edition: 227-259.
4. Lachman L., Liberman L. and Schwartz J.; Pharmaceutical Dosage Forms: Tablets; Second Edition : Volume I.
5. Remington J., Remington: The Science and Practice of Pharmacy; Nineteenth Edition: Volume II : 1615-1641.
6. American Pharmaceutical Reviews; 2001; 4(3): 28-35.
7. Vyas S. and Khar R.; Controlled Drug Delivery Concepts and Advances; First Edition: 219-256.
8. Pharmaceutical Approaches to Colon Targeted Drug Delivery Systems.
10. Oral Disintegrating Technologies.
11. effervescent dosage manufacturing.
13. Swarbrick J. and Boylan J.; Encyclopedia of Pharmaceutical Technology; Volume 14: 355-348, 385-400, 401-418.
14. Chowhan Z.; Pharmaceutical Technology: Excipients and their functionality in drug product development; 1993; (9).
15. Taylor and Francis; International Journal of Toxicology: Toxicity of excipients- A food and drug administration perspective; 2003; 22(5): 377-380.
16. Banker G. and Rhodes C.; Drug and Pharmaceutical Sciences: Modern Pharmaceutics; Third Edition; Volume 72: 333-394.
17. Swarbrick J and Boylan J.; Encyclopedia of Pharmaceutical Technology; Volume 4: 37-84, 85-106.
18. Rowe R., Sheskey P. and Weller P.; Handbook of Pharmaceutical Excipients; Fourth Edition.
19. lactose.
20. Parteck™M Directly Compressible Mannitol.
21. Kachrimanis K., Nikolakakis L. and Malamataris S.; Journal of Pharmaceutical Sciences: Tensile Strength and disintegration of tableted silicified Microcrystalline Cellulose. Influence of interparticle bonding; 2003; 92(7): 1489-1501.
22. Schlack H., Bauer-Brandl A., Schubert R. and Becker D.; Drug Development and Industrial Pharmacy: Properties of Fujicalin, a new modified anhydrous dibasic calcium phosphate for direct compression and comparison with dicalcium phosphate dihydrate; 2001; 27(8): 789-801.
24. Swarbrick J and Boylan J.; Encyclopedia of Pharmaceutical Technology; Volume 7: 121-160.
25. Swarbrick J and Boylan J.; Encyclopedia of Pharmaceutical Technology; Volume 1: 451-464.
26. Starch1500® 27. HPMC.
28. Polyvinyl pyrrolidone for technical application.
29. Zhang Y. and Chakrabarti S.; National Starch and Chemicals; AAPS Meeting Torento; Direct Compression Binder-Characteristic and functionality of commercial binders; 2002; Abstract # 4332
30. Swarbrick J and Boylan J.; Encyclopedia of Pharmaceutical Technology; Volume 16: 363-402.
31. Jorgensen A., Luukkonen P., Rantaren J., Schefer T., Juppo A. And Yllruusi J.; Jouranl of Pharmaceutical Sciences: Comparison of torque measurements and near-infrared spectroscopy in characterization of a wet granulation process; 2004; 93(9): 2232-2243.
32. Anneke M., Marinella R., Auko C., Johannes A. and Henderik W.; European Journal of Pharmaceutical Sciences; 2004; 23(2): 169-179.
33. Ferrari F., Bertoni M., Bonferoni M. and Rossi S.; International Journal of Pharmaceutics: Investigation on bonding and disintegration properties of pharmaceutical materials; 1996; 13: 71-79.
34. Guyot-Hermann; S.T.P. Pharmaceutical Science: The disintegration and disintegrating agent; 1992; 2(6): 445-462.
35. Boltzolaski and Augsburger; Drug Development and Industrial Pharmacy: Disintegrating agents in hard gelatin capsules; 1998; 14(9): 1235-1248.
36. Lowenthal W.; Journal of Pharmaceutical Sciences: Disintegration of tablets; 1972; 61(11): 1695-1711.
37. P.H.List and Muazzam V.; Drug Made Ger; 1985; 22: 161-163.
38. Patel N. and Hopponen R.; Journal of Pharmaceutical Sciences: Mechanism of action of starch as disintegrating agent in aspirin tablets; 1966; 55(10): 1065-1068.
39. mechanism of disintegration
40. Lowenthal W. and Wood J.; Journal of Pharmaceutical Sciences: Mechanism of action of starch as Tablet disintegrant VI : Location and structure of starch in tablet; 1973; 62(2): 287-293.
41. Rudnic E., Kanig J. and Rhodes C.; Journal of Pharmaceutical Sciences: Effect of molecular structure variation on the disintegrant action of sodium starch glycolate; 1985; 74(6): 647-650.
42. Burlinson H. and Pickering C.; Journal of Pharmacy and Pharmacology: The disintegration of Tablet; 1950; 2(6): 630-638.
43. Aslam A. and Parrott E.; Journal of Pharmaceutical Sciences: Effect of aging on some physical properties of Hydrochlorthiazide tablets; 1971; 60(2): 263-266.
44. Chebli C. and Cartlizer L.; International Journal of Pharmaceutics: Crosslinked cellulose as a tablet excipient: A binding or disintegrating agent; 1998; 171: 101-110.
45. nutrasweet.com
46. Chofetz L.; Journal of Pharmaceutical Sciences: Stability Indicating assay method for drugs and their dosage forms; 1971; 60(3): 335-345.
47. Eyjolfsson R.; Drug Development and Industrial Pharmacy: Lisinopril- Lactose Incompatibility; 1998; 24(8): 797-798.
48. Gold G., Duvall R., Palermo B. and Slater J.; Journal of Pharmaceutical Sciences: Powder flow studies III- Factors affecting flow of lactose granules; 1968; 57(4): 667-671.
49. Danish F. and Parrott E.; Journal of Pharmaceutical Sciences: Flowrates of solid particulate pharmaceuticals; 1971; 60(4): 548-554.
50. Jones T.; Journal of Pharmaceutical Sciences: Mechanism of flow improvement by addition of fine particles to bulk solids; 1968; 57(11): 2015-2016.
51. Martin E.; Dispensing of Medication; Edition Seventh: 740-741.
52. Cadwallader D. and Islam Q.; Journal of Pharmaceutical Sciences: Urea as a tableting agent for benzalkonium chloride; 1969; 58(1): 238-241.
53. Shabbir D. and Rhodes C.; Drug Development and Industrial Pharmacy: The effect of moisture on powder flow and on compaction and physical stability of tablets; 1989; 15(10): 1577-1600.
54. Alderborn G. and Nysrom C.; Drugs and Pharmaceutical Sciences: Pharmaceutical Powder Compaction Technology: Volume 71: 11-12.
55. Gold G. and Palermo B.; Journal of Pharmaceutical Sciences: Hopper flow electrostatics of tableting material I; 1965; 54(2): 310-312.
56. Nystrom C., Mazur J. and Sjogren J.; International Journal of Pharmaceutics: Studies of direct compression of tablets II- The influence of particle size of a dry binder on the mechanical strength of tablets; 1982; 10(3): 209-218.
57. Parikh D.; Drugs and Pharmaceutical Sciences: Handbook of Pharmaceutical Granulation Technology; Volume 81.
58. Ullah I., Carras R., Wiley G. and Lipper R.; Pharmaceutical Technology: Moisture activated dry granulation technique- A general process; 1987; 11(9): 48.
59. Aniruddha M., Railkar and Schwatz J.; Drug Development and Industrial Pharmacy: Use of moist granulation technique (MGT) to develop controlled release dosage forms of Acetaminophen; 2001; 27(4): 337-343.
60. Shoung Y. and Hungting Y.; United State Patent Application: Process for the preparation of direct tableting formulation and aids; 20030017198; 2003; 23(1).
61. Kerry C. and Sheskey P.; Preliminary report of discovery of a new pharmaceutical granulation process using foamed aqueous binder: Larjin Laboratory, The Dow Chemical Company; Midland, Michigan, USA.
62. Lachman L., Liberman L. and Schwartz J.; Pharmaceutical Dosage Forms: Tablets; Second Edition : Volume II.
63. Section 3- Compression/compaction by Dr. Keith Marshall
64. McGinity J.; Drug and The Pharmaceutical Sciences: Aqueous polymeric coatings for pharmaceutical dosage forms; Volume 36: 419-428.
65. Indian Pharmacopoeia; 1996.
66. British Pharmacopoeia; 2001.
67. The United State Pharmacopoeia 24; The National Formulary 19; 2000.
Go to Contents of Tablet:The Ruling Dosage Form Since
Years>>>>>>
Retrieved from "http://www.pharmpedia.com/Tablet:The_Ruling_Dosage_Form_Since_Years/References"
This page has been accessed 1,394 times. This page was last modified 21:22, 8 August 2005. All content, except where otherwise noted, is licensed under a Creative Commons Attribution License.
